Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL2N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,140
Award facts
- Contract value 100% obligated
- $58,140.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,140.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This is a non-set-aside, competitively awarded contract with an ultimate completion date of January 23, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the comprehensive vehicle for pharmaceutical and medical supply deliveries to support military healthcare systems globally.
AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial portfolio of federal contracts delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military treatment facilities and veteran healthcare programs. The DLA Troop Support Medical contract encompasses a broad range of pharmaceutical commodities including specialty medications, injectable drugs, and critical care materials necessary to support military healthcare operations worldwide, positioning AmerisourceBergen as a critical vendor within the federal medical procurement supply chain.
Quick answers
Who was awarded contract SPE2DR26FFL2N?
SPE2DR26FFL2N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FFL2N worth?
The government has obligated $58,140 on SPE2DR26FFL2N.
Is contract SPE2DR26FFL2N an order under another contract?
Yes. SPE2DR26FFL2N is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL2N competed?
The extent of competition for SPE2DR26FFL2N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award